Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

NK cells play a role in skin diseases like eczema and psoriasis.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Dupilumab for eczema may cause hair loss.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Dupilumab may help regrow hair in people with atopic dermatitis.

Apremilast improved symptoms in patients with severe skin conditions.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Dupilumab can cause rare side effects like a rash on the face and neck.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Many Korean patients with hair loss, skin allergies, and psoriasis use alternative medicine, but satisfaction is low.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

A medication for skin rash also unexpectedly treated hair loss in a patient.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Korean Red Ginseng may improve skin condition and reduce allergy markers in atopic dermatitis patients.

Atopic dermatitis increases the risk of some autoimmune diseases.

Dupilumab for skin problems might reactivate hair loss in some patients.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.